Amarin (United Kingdom)
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Amarin (United Kingdom), United Kingdom, covering academic research published from 2004 to 2025. Read More.
Open Access Percentage
42%
Total
Publications
216
Total Open
Publications
91
Total
Citations
2.3K
Open Access
Percentage
42%
Total
Publications
216
Total Open
Publications
91
Total
Citations
2.3K
Breakdown
Publisher Open
29%
Both
13%
Other Platform Open
1%
Closed
57%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 30%
27
Hybrid 16%
15
No Guarantees 54%
50
Other Platform Open
Domain 77%
24
Institution 68%
21
Public 3%
1
Other Internet 3%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 25 |
doaj.org OAI-PMH Repository | Institution | 11 |
University of Groningen | Institution | 4 |
Royal Netherlands Academy of Arts and Sciences | Institution | 3 |
aecid.es OAI-PMH Repository | Institution | 2 |
White Rose University Consortium | Institution | 1 |
Unknown Repository | Other Internet | 1 |
University of Oxford | Institution | 1 |
University of Milano-Bicocca | Institution | 1 |
University of Dundee | Institution | 1 |